Kura Share Price

Kura Share Price

NASDAQ: KURA | Small Cap | Healthcare
$6.90
-$0.44 (-6.06%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Kura Stock Performance

Open
$7.17
Prev. Close
$7.34
Circuit Range
N/A
Day Range
$6.89 - $7.36
Year Range
$6.77 - $13.89
Volume
55,884
Average Traded
$7.07

Kura Share Price Today

As of 21 November 2026, Kura Oncology, Inc.'s share price is $6.90. The stock opened at $7.17, compared to its previous close of $7.34. During today's trading session, Kura Oncology, Inc.'s share price traded between $6.89 and $7.36, with an average price of $7.12. Over the past 52 weeks, the stock has recorded a high of $13.89 and a low of $6.77. In terms of performance, Kura Oncology, Inc.'s share price has declined by 32.42% over the last six months and is down 43.26% on a year-on-year basis.

Kura Share Price Chart

Line chart of the Kura price trend over the selected period. The price fell overall, ranging from 6.90 to 7.33, ending at 6.90.
$6.89$7.36
L
Show Current Price
H

Kura Stock Fundamentals & Key Indicators

Market Cap
$604.96M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.19
Revenue (TTM)
$67.48B
Return On Equity (TTM)
-1630.70%
Profit Margin
-412.97%
Debt to Equity
0.55
Quarterly Earnings Growth YoY
13.31%

Kura Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$17.34$18.27$20.87$22.84
Net Profit-$81.00-$73.33-$68.33-$70.22
Net Profit Margin-467.13%-401.37%-327.41%-307.44%
Income ChangeN/A9.47%6.82%-2.77%

Kura Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$53.88$67.48
Net Profit-$135.84-$152.63-$173.98-$278.67
Net Profit MarginN/AN/A-322.90%-412.97%
Income ChangeN/A-12.36%-13.99%-60.17%

Kura Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets29.715.3316.459.88
Current Assets708.66744.83432.48446.43
Total Assets738.36760.16448.94456.31
Non Current Liabilities447.25267.8116.411.97
Current Liabilities116.9778.7135.2624.06
Total Liabilities564.23346.5251.6636.03
Shareholders' Equity174.14413.64397.27420.28

Kura Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-64.06134.32-124.82-110.06
Investing-13.1-101.5915.5632.63
Financing1.79154.4294.7838.57

About Kura

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Kura Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$10.31
$6.91
-32.80%
Oct 2026
$10.89
$10.28
-3.97%
Sep 2026
$12.65
$10.70
-18.79%
Aug 2026
$8.92
$13.18
+46.06%
Jul 2026
$10.99
$9.02
-17.70%
Jun 2026
$9.97
$10.96
+7.35%
May 2026
$8.74
$10.21
+15.63%
Apr 2026
$8.21
$8.83
+8.61%
Mar 2026
$8.72
$8.13
-6.87%
Feb 2026
$8.08
$8.73
+7.53%
Jan 2026
$10.36
$8.12
-21.78%
Dec 2025
$12.05
$10.38
-14.64%

Kura Share Price FAQs